ESR1 and prostate carcinoma: Furthermore, FliI modulates cell proliferation and survival in cancer cells by interacting with transcription factors such as androgen receptor, estrogen receptor (ER), and carbohydrate responsive element-binding protein, which regulate tumor progression in prostate cancer and CRC cells21–23.